Thiopurine Metabolism in the Era of Combotherapy

Abstract : 6-thioguanine nucleotides levels are associated with clinical remission in patients with inflammatory bowel disease (IBD) on thiopurine monotherapy. Recently, few studies investigated the interaction between thiopurine metabolism and anti-tumor necrosis factor therapy among patients with IBD on combotherapy. Two studies demonstrated that infliximab therapy increases 6-thioguanine nucleotides level, while such effect could not be observed with adalimumab. Three studies showed that a Delta mean corpuscular volume >7 and high 6-thioguanine nucleotides levels are associated with favorable outcomes, i.e., greater mucosal healing rates, and have a positive impact on the pharmacokinetics of infliximab. These results suggest a synergistic effect between thiopurine metabolism and anti-tumor necrosis factor therapy, especially with infliximab. We propose here some algorithms for clinical practice integrating thiopurine metabolism in patients with IBD on combotherapy. Further randomized controlled trials are needed to further investigate the relationships between thiopurine metabolism and anti-tumor necrosis factor therapy and to establish the clinical utility of measuring thiopurines' metabolites in these patients in clinical practice. Whether measuring thiopurine metabolism can be used to guide decision-making in patients with IBD on combotherapy when considering drug de-escalation or discontinuation will require further investigation.
Type de document :
Article dans une revue
Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2016, 22 (6), pp.1496 - 1501. 〈10.1097/MIB.0000000000000737〉
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01666531
Contributeur : Ngere Ul <>
Soumis le : lundi 18 décembre 2017 - 14:50:56
Dernière modification le : lundi 23 avril 2018 - 15:53:20

Identifiants

Citation

Xavier Roblin, Nicolas Williet, Laurent Peyrin-Biroulet. Thiopurine Metabolism in the Era of Combotherapy. Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2016, 22 (6), pp.1496 - 1501. 〈10.1097/MIB.0000000000000737〉. 〈hal-01666531〉

Partager

Métriques

Consultations de la notice

24